AIM ImmunoTech shareholders approve reverse stock split up to 1-for-100

AIM ImmunoTech Inc.

Special meeting held April 30, 2025; proposal passed with 23,041,332 for, 19,942,903 against.
Board may enact reverse split at any ratio up to 1-for-100 at its sole discretion.
Split intended to increase per-share price; no specific ratio or effective date announced.

item 5.07 item 9.01

AIM ImmunoTech Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-007954

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.